TARGET Intracranial Aneurysm Coiling Registry



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:7/26/2018
Start Date:February 2013
End Date:March 2019
Contact:Victoria J Calderon, MPH
Email:vcalderon@mercy.com
Phone:4192514367

Use our guide to learn which trials are right for you!

TARGET Intracranial Aneurysm Coiling Registry: A Prospective Clinical Efficacy and Safety Study of Stryker Target® 360°, Target® Helical, and 2nd Generation Target® Nano Coils

The purpose of this prospective registry is to collect real world, post-marketing data on the
use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the
embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients
(150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial
aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc
analysis comparing Target® 360° and Target® 2D coil technical and clinical endpoints will be
performed.


Inclusion Criteria:

1. Patient is 18 years or older.

2. Patient has a documented, previously untreated, saccular intracranial aneurysm,
unruptured or ruptured, suitable for embolization with coils.

3. (NEW NANO arm ONLY) Target aneurysm is ≤7mm.

4. Patient has a Hunt and Hess Score of 3 or less.

5. Patient has a premorbid mRS of 3 or less.

6. Patient or patient's legally authorized representative has provided written informed
consent.

7. Patient is willing to and can comply with study follow-up requirements.

Exclusion Criteria:

1. Patient is < 18 years old.

2. Dissecting aneurysm.

3. Patients with intracranial aneurysms (other than the target aneurysm) that will
require treatment during the study period (enrollment through follow-up).

4. Patients in whom the target aneurysm will be treated with coils other than Stryker
Target® 360°, Target® Helical coils, and 2nd generation Target® Nano Coils.

5. (NEW NANO Arm ONLY) Patients in whom the target aneurysm was treated with a total coil
length comprised of <25% Stryker Target® 2nd generation Nano Coils.

6. Target aneurysm is fusiform.

7. Patients in which the target aneurysm cannot be coiled in one procedure (i.e. staged
procedure)
We found this trial at
9
sites
Tallahassee, Florida 32308
Principal Investigator: Matthew Lawson, MD
924
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Flint, Michigan 48532
Principal Investigator: Aniel Q Majjhoo, MD
?
mi
from
Flint, MI
Click here to add this to my saved trials
Greenville, South Carolina 29615
Principal Investigator: Mahmoud Rayes, MD
880
mi
from
Greenville, SC
Click here to add this to my saved trials
Joliet, Illinois 60435
Principal Investigator: Aamir Badruddin, MD
577
mi
from
Joliet, IL
Click here to add this to my saved trials
Morgantown, West Virginia
Principal Investigator: Ansaar Rai, MD
970
mi
from
Morgantown, WV
Click here to add this to my saved trials
550 East Van Buren Street
Phoenix, Arizona 85004
Principal Investigator: Peter J Sunenshine, MD
852
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Saint Louis, Missouri 63132
Principal Investigator: Amer Alshekhlee, MD
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Toledo, Ohio 43608
Principal Investigator: Osama O Zaidat, MD, MS
Phone: 419-251-4367
805
mi
from
Toledo, OH
Click here to add this to my saved trials
55 N Lake Ave
Worcester, Massachusetts 01655
(508) 856-8989
Principal Investigator: Ajit Puri, MD
Univ of Massachusetts Med School As the commonwealth's only public medical school, we take seriously...
1405
mi
from
Worcester, MA
Click here to add this to my saved trials